Drug Information Analysis Service

Kapikian AZ . The common cold. In: Wyngaarden JB Smith LH Jr , eds. Cecil textbook of medicine. Philadelphia: WB Saunders, 1988: 1753–6.

Pasternak CA . A novel form of host defense: Membrane protection by Ca2+ and Zn2+. Biosci Rep 1987; 7 (2): 81–91.

Geist FC Bateman JA Hayden FG . In vitro activity of zinc salts against human rhinoviruses. Antimicrob Agents Chemother 1987; 31: 622–4.

Korant BD Kauer JC Butterworth BE . Zinc ions inhibit replication of rhinoviruses. Nature 1974; 248: 588–90.

Korant BD Butterworth BE . Inhibition by zinc of rhinovirus protein cleavage: Interaction of zinc with capsid proteins. J Virol 1976; 18: 298–306.

Eby GA Davis DR Halcomb WW . Reduction in duration of common colds by zinc gluconate lozenges in a double-blind study. Antimicrob Agents Chemother 1984; 25: 20–4.

Al-Nakib W Higgins PG Barrow I Batstone G Tyrrell DAJ . Prophylaxis and treatment of rhinovirus colds with zinc gluconate lozenges. J Antimicrob Chemother 1987; 20: 893–901.

Farr BM Gwaltney JM Jr . The problems of taste in placebo matching: An evaluation of zinc gluconate for the common cold. J Chron Dis 1987; 40: 875–9.

Farr BM Conner EM Betts RF Oleske J Minnefor A Gwaltney JM Jr . Two randomized controlled trials of zinc gluconate lozenge therapy of experimentally induced rhinovirus colds. Antimicrob Agents Chemother 1987; 31: 1183–7.

Douglas RM Miles HB Moore BW Ryan P Pinnock CB . Failure of effervescent zinc acetate lozenges to alter the course of upper respiratory tract infections in Australian adults. Antimicrob Agents Chemother 1987; 31: 1263–5.

Weismann K Jakobsen JP Weismann JE Hammer UM Nyholm SM Hansen B , Zinc gluconate lozenges for the common cold. Dan Med Bull 1990; 37: 279–81.

Smith DS Helzner EC Nuttall CE Jr Collins M Rofman BA Ginsberg D , Failure of zinc gluconate in treatment of acute upper respiratory tract infections. Antimicrob Agents Chemother 1989; 33: 646–8.

Godfrey JC Sloane BC Smith DS Turco JH Mercer N Godfrey NJ . Zinc gluconate and the common cold: A controlled clinical study. J Int Med Res 1992; 20: 234–46.

Zarembo JE Godfrey JC Godfrey NJ . Zinc (II) in saliva: Determination of concentrations produced by different formulations of zinc gluconate lozenges containing common excipients. J Pharm Sci 1992; 81: 128–30.

Godfrey JC . Zinc for the common cold (letter). Antimicrob Agents Chemother 1988; 32: 605.

Eby GA . Stability constants of zinc complexes affect common cold treatment results (letter). Antimicrob Agents Chemother 1988; 32: 606.

Farr BM Hayden FG Gwaltney JM Jr . Untitled (letter). Antimicrob Agents Chemother 1988; 32: 607.

Winther B Gwaltney JM Jr Mygind N Turner RB Hendley JO . Sites of rhinovirus recovery after point inoculation of the upper airway. JAMA 1986; 256: 1763–7.

Miller DR Hoag SG . Personal care products. In: Davidson DE , ed. Handbook of nonprescription drugs. 8th ed. Washington DC: American Pharmaceutical Association, 1986: 410–1.

Chren MM Bickers DR . Dermatological pharmacology. In: Gilman AG Rall TW Nies AS Taylor P , eds. Goodman and Gilman's the pharmacological basis of therapeutics. 8th ed. New York: Pergamon Press, 1990: 1572–91.

Johnson ML . Skin diseases. In: Wyngaarden JB , ed. Cecil textbook of medicine. 17th ed. Philadelphia: WB Saunders, 1985: 2254–6.

Arndt KA Fitzpatrick TB . Topical use of hydroquinone as a depigmenting agent. JAMA 1965; 194: 965–7.

Dorsey CS . Dermatitic and pigmentary reactions to monobenzyl ether of hydroquinone. Arch Dermatol 1960; 81: 245–8.

Jimbow D Obata H Pathak MA Fitzpatrick TB . Mechanism of depigmentation by hydroquinone. J Invest Dermatol 1974; 62: 436–49.

Spencer MC . Topical use of hydroquinone for depigmentation. JAMA 1965; 194: 962–4.